Live feed08:00:00·117dPRReleasevia QuantisnowGenelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer TrialsByQuantisnow·Wall Street's wire, on your screen.GNLX· Genelux CorporationHealth Care